Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-10 Ruffo Frank Chief Financial Officer Sale −12,823 $15.55 $199K 201,883
2022-03-02 Ruffo Frank Chief Financial Officer Option exercise +8,297 214,706
2022-03-02 Ruffo Frank Chief Financial Officer Option exercise · Restricted stock units −8,297 16,595
2022-03-01 Ruffo Frank Chief Financial Officer Option exercise +25,750 198,109
2022-03-01 Ruffo Frank Chief Financial Officer Option exercise +8,300 206,409
2022-03-01 Ruffo Frank Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +155,200 155,200
2022-03-01 Ruffo Frank Chief Financial Officer Grant or award · Restricted stock units +44,300 44,300
2022-03-01 Ruffo Frank Chief Financial Officer Option exercise · Restricted stock units −25,750 25,750
2022-03-01 Ruffo Frank Chief Financial Officer Option exercise · Restricted stock units −8,300 24,900
2022-02-09 Ruffo Frank Chief Financial Officer Sale −1,388 $12.66 $18K 172,359
2022-02-01 Ruffo Frank Chief Financial Officer Option exercise +3,875 173,747
2022-02-01 Ruffo Frank Chief Financial Officer Option exercise · Restricted Stock Units −3,875 0
2021-06-02 Ruffo Frank Chief Financial Officer Sale −12,587 $21.51 $271K 172,322
2021-06-02 Ruffo Frank Chief Financial Officer Sale −2,450 $22.30 $55K 169,872
2021-06-01 Ruffo Frank Chief Financial Officer Option exercise +33,189 184,909
2021-06-01 Ruffo Frank Chief Financial Officer Option exercise · Restricted Stock Units −33,189 0
2021-04-26 Ruffo Frank Chief Financial Officer Sale −27,239 $25.79 $703K 151,820
2021-04-26 Ruffo Frank Chief Financial Officer Sale −100 $26.44 $3K 151,720
2021-04-23 Ruffo Frank Chief Financial Officer Sale −29,200 $26.64 $778K 179,859
2021-04-23 Ruffo Frank Chief Financial Officer Sale −800 $27.33 $22K 179,059

Page 1 of 5 · 88 trades